All News

Cebranopadol is a first-in-class investigational therapy that targets the nociceptin/orphanin FQ receptor and the µ-opioid receptor.

The US government is entrusting mRNA vaccine pioneers Moderna to develop protection for the gradually increasing threat of avian influenza.

Erin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.

Kurt Proctor, PhD, RPh, President of the NCPA Innovation Center, discussed his organization’s efforts in launching the Independent Community Pharmacy Consortium for Government Engagement.

For adults with obesity but no diabetes diagnosis, researchers searched for the key factors leading to semaglutide initiation.

The approval makes Johnson and Johnson’s esketamine nasal spray the first and only monotherapy for the treatment of major depressive disorder in adult patients.

Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed a section of the ASHP 2025 Pharmacy Forecast that he co-authored titled “Addressing the Gap in Primary Care.”

The lawsuit alleges Walgreens has been filling prescriptions in violation of the Controlled Substances Act since 2012.

A conversation with Antonia Biggs, PhD, professor and acting director of the Advancing New Standards in Reproductive Health Program at the University of California, San Francisco.

A poll conducted by the Global Healthy Living Foundation found 11% of respondents with chronic conditions do not plan to get vaccinated for flu, COVID-19 or RSV.

Researchers wanted to better understand the accuracy of advertising practices behind websites selling compounded GLP-1 RAs.

Support for and personal interest in expanded access to advance provision and over-the-counter medication abortion has increased significantly since the constitutional right to abortion was overturned by the Supreme Court.

Known as “The Nutrition Pharmacist,” Sarah Gray, PharmD, GAICD, recently joined Drug Topics to discuss her dual profession within health care.

A conversation with Jennifer Bacci, PharmD, MPH, endowed associate professor of Innovative Pharmacy Practice at the University of Washington School of Pharmacy.

Researchers compared the safety and reactogenicity of simultaneous doses of recombinant zoster vaccine paired with 2 separate types of inactivated influenza vaccines.

The therapy is the first and only prefilled testosterone cypionate injection approved by the FDA.

There are a lack of data available on the optimal antiviral medication for nonsevere flu.

Sarah Gray, PharmD, GAICD, explored the unique combination of being both a pharmacist and nutritionist.

A conversation with David Nau, PhD, professor of social and administrative pharmacy, and director of assessment at Ohio Northern University.

RGT-075 from Regor Therapeutics demonstrated a statistically significant 5% placebo-adjusted weight loss in adult patients with obesity or overweight.

The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.

Ahead of its first general meeting in 2025, lawmakers called on the FTC to vote “yes” on releasing a second interim staff report on PBMs.

A conversation with Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM.

A combination of ibuprofen and acetaminophen was found to be superior to hydrocodone and acetaminophen in managing pain after impacted mandibular third-molar extraction surgery.

Rite Aid recently released a survey detailing US patients’ perspective of how they engage with their pharmacists.

Sarah Gray, PharmD, GAICD, discussed her experience as a pharmacist who added nutrition counseling to her clinical expertise.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.

To celebrate National Pharmacists Day on January 12, Drug Topics gathered its pharmacist interviews from the past year, exploring expert industry insights in a variety of topics.